6 of 10 pharma distribution companies recorded increase of sales costs

It was observed 6 of 10 pharmaceutical distribution companies had difficulties with the enlarged sales costs in the total sales.

According to the analysis result of 145 pharmaceutical distribution companies’ 2016 audit reports turned in to the Financial Supervisory Service, their sales costs were KRW 16.2909 trillion, accounting for 92.1% of the total KRW 17.6876 trillion sales. The ratio was ...